Nicky Agahari is the founder of Australis Scientific, a pioneering medtech-as-a-service platform known for its In-Confidence™ Smart Patch technology, which aims to expedite care for individuals experiencing urinary symptoms. Prior to establishing Australis Scientific, Nicky carved out a distinguished 15-year career as a corporate innovator and intrapreneur. Throughout this time, he excelled in achieving strategic and commercial objectives, both as an individual contributor and in leadership capacities with profit and loss (P&L) responsibility. Agahari's core competencies lie in leading commercialization campaigns that address unmet needs, thus delivering substantial value.

Educated at Harvard (Health Tech Fellow 22) and MIT (MIT Bootcamp Global Healthcare Innovation Coach), Nicky's approach to innovation is rooted in creating value through ethnographic research and data-driven decision-making. With a deep understanding of global product lifecycle management and innovation frameworks, Agahari not only possesses extensive knowledge in these areas but also has experience teaching these concepts and implementing them in real-world scenarios.

Throughout Nicky's career, there has been a consistent track record of surpassing annual commercial targets and spearheading successful marketing and sales campaigns across diverse regions including the USA, Greater China, Australia, and the Asia Pacific region.

Danielle is a fully accredited Urologist having completed her medical training at the University of Sydney and the Northern Clinical School (Royal North Shore Hospital). Danielle developed a passion for Paediatric Urology and spent several years in Paediatric and General surgery training throughout metropolitan and rural NSW prior to commencing her formal Urology training in Victoria. Once completing General Urology training in Melbourne in 2006, she returned to Sydney in 2007 completing a Fellowship in Paediatric Urology at Sydney Children’s Hospital, Randwick. After completing a Fellowship in Paediatric Urology, Danielle spent some time working in Shanghai, China in Paediatric Urology. Once returning to Sydney in 2009, she commenced consultant practice with a public position at the Sydney Children’s Hospital Network and locum services to several established colleagues throughout Sydney.  Then Danielle opened a private practice offering services to both adults and children. Danielle has recently served as Head of Urology for Sydney Children’s Hospital.

In adults, she has a special interest in endoscopic urology including renal calculi and bladder cancer. In children she has a special interest in congenital kidney and bladder pathology, renal calculi and voiding issues. Danielle provides antenatal consultations for congenital urological conditions and is often involved complex pregnancies of both maternal and foetal origin.

Danielle has extensive experience in kidney and bladder stone surgery and can provide all minimally invasive techniques such as flexible ureteroscopy and percutaneous nephrolithotomy. She is one of the few Urologists accredited to operate on children with kidney stones and is involved in NSW paediatric multi-disciplinary stone service at Sydney Children’s Hospital Network. Danielle has a special interest in functional urology and is passionate about optimising bladder function from birth to death. A Sydney Children’s Hospital, Randwick, she has improved management of continence issues for children and adolescents. She has been involved in two international clinical trials for Overactive Bladder (OAB) in adolescents and neurogenic bladder in children and adolescents. Danielle often works as a proctor instructing urological colleagues on subspecialised procedures such as sacral neuromodulation for urinary incontinence. Danielle has been recognised as an expert in managing refractory OAB and is often requested to speak on behalf of the Urological Society of Australia and New Zealand and the Continence Foundation of Australia, including facilitating workshops on intravesical Botulinum toxin A. Danielle performs urodynamics evaluations in the clinic utilising ultrasound, preventing unnecessary exposure to radiation. She is able to provide a complete range of management for urinary incontinence including stress urinary incontinence.

M. Martin Jensen is a biomedical engineer working at the interface of technology and medicine. He received departmental and university honors for his B.S. in Chemistry at the University of Utah. During his undergrad, he worked at Catheter Connections Inc. and was responsible for developing an FDA cleared IV-line disinfecting system using the Dualcap® technology that was 6 times faster than competing products at the time and is still twice as fast as competing technologies. During his doctoral work at the University of Utah, he received a National Science Foundation (NSF) Graduate Research Fellowship and a NSF INTERN award to pursue industry experience. His research focused on developing and translating innovative technologies including gels to protect soft tissues from radiation damage, embolics to treat cerebral aneurysms, markers to guide surgical resection of tumors, IVD tests for high complexity labs (CLIA and CAP), and nanotechnology delivery systems to improve the selectivity of herbicides. While as a post-doctoral research fellow with Harvard Medical School mentored by Jeff Karp and Siam Oottamasathien where he developed a prize-winning body fluid management technology for the United States Airforce. He completed his entrepreneurial training with MIT Boot Camp for Entrepreneurship and Innovation in Biomedical Product Development and Harvard HealthTech Fellowship.

Dr Helena Franco completed a Bachelor of Medical Studies/Doctor of Medicine (MD) from Bond University and received the 2018 Bond University Young Alumni of the Year award in recognition of her academic success. She subsequently completed a Master of Medical Sciences in Global Health Delivery at Harvard Medical School as an R.G Menzies Scholar of Australia. In 2023, she led the InConfidence team to win the prestigious Harvard President’s Innovation Challenge!

Through her clinical career in surgery, she has developed an interest in the process of business development and research to expand access to healthcare infrastructure. She participated in the HMS-MIT Healthcare Innovation Bootcamp, where her team came runner-up after creating a platform to re-create the food experience for patients with dysphasia. She advanced her knowledge of health innovation through the LatinX Venture Capital Fellowship and was a 2023 Flare Capital Scholar.

Dr Mihir Shanker is Specialist Radiation Oncologist and currently Co-Founder and Chief Operating Officer of Australis Scientific. Dr Shanker completed his medical degree at The University of Queensland in 2014 and was awarded Fellowship of the Royal and Australian and New Zealand College of Radiologists (FRANZCR) in 2022. He completed further specialty training as the Garry Reichart Gamma Knife Fellow at the Princess Alexandra Hospital and completed an Advanced Radiation Oncology Fellowship at The University of Texas MD Anderson Cancer Center in Houston, USA in 2023.  Dr Shanker is a graduate of the Massachusetts Institute of Technology (MIT) New Ventures Leadership Program and is a Certified Health Informatician in Australasia (CHIA). He has a background in Biomedical Engineering with Honours, holds a Master of Philosophy (Research) and a Master of Medicine (Clinical Epidemiology and Biostatistica) from The University of Sydney. He is a Member of the Australian Institute of Company Directors (MAICD).

Dr Shanker has published in multiple peer-reviewed journals in fields of brain metastases, spine metastases, primary brain tumours, radiomics and machine learning and upper gastrointestinal malignancies and in collaboration with national and international clinicians. He has published textbook chapters on the topic of spine stereotactic radiotherapy and brain radiation toxicities. He has presented at numerous national and international conferences and is a peer reviewer for several radiation oncology journals. Dr Shanker has worked as a visiting scientist at the Sid Faithful Brain Cancer Laboratory at the Queensland Institute of Medical Research and in the Chung Computational Imaging Laboratory at the MD Anderson Cancer Center.

Dr Shanker is a recipient of the Cooperative Trials Group in Neuro Oncology (COGNO) and Gastrointestinal Society of Queensland (GESQ) Young Investigator of the Year awards. He was awarded The Varian Prize for best oral presentation at the RANZCR Annual Meeting and COGNO Best Oral Presentation prize in 2021. He has received a PA Research Foundation Prize and has been awarded over $950K in competitive grant funding. He received the Uhr Clarke Examination award in 2020 and recently has been part a team which won the Harvard University President’s Innovation Challenge for development of novel peripheral neuromodulation technology. Dr Shanker holds an academic position as Senior Lecturer at The University of Queensland. He is actively involved in education of medical students and trainees. He is a member of the American Society for Radiation Oncology (ASTRO), European Society for Radiotherapy and Oncology (ESTRO), International Stereotactic Radiosurgery Society (ISRS) and the Harvard Innovation Lab.

Mr. Matthew Dawson is a seasoned professional with over 10 years of experience in the health industry, showcasing a wealth of expertise in healthcare management and operations. His journey began with a solid foundation in fitness management, where he honed his leadership skills during his tenure managing gyms for four years. Recognizing his passion for healthcare, Matthew transitioned to House Call Doctor, embarking on a remarkable journey.

Starting from the ground up, Matthew diligently worked his way through the ranks at House Call Doctor, demonstrating unwavering dedication and expertise. His commitment to excellence and innovative mindset propelled him to the position of General Manager. In this influential role, Matthew spearheaded transformative initiatives, driving operational efficiency, and significantly enhancing patient care.

A notable accomplishment during his tenure at House Call Doctor was the successful implementation of a catheter replacement program. Matthew identified a critical need within the organization and devised a comprehensive program for in-house replacements. Through meticulous planning and execution, he ensured seamless operations and markedly improved patient outcomes.

With over a decade-long career in the health industry, Matthew's leadership, strategic vision, and hands-on approach have been instrumental in driving success and achieving organisational goals. His dedication to delivering high-quality healthcare services and improving operational effectiveness continues to make a significant impact in the healthcare industry.

Beyond his professional endeavours, Matthew enjoys staying active, exploring new fitness routines, and cherishing quality time with family and friends. His unwavering commitment to excellence and passion for making a difference set him apart as a dynamic leader and valued asset in any organisation.